Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for intractable vascular anomalies
jRCTs031180290Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sirolimus in vascular abnormality, Vasculopathy and lymphatic diseases, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Adverse effects and side effects. Started Mar 2019; status: completed.
02
Drugs
sirolimus
03
Conditions
vascular abnormalityVasculopathylymphatic diseases
Beyond the preview
Go deeper on jRCTs031180290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180290.